Martin Shkreli, the 30-year-old hedge fund manager turned biotech CEO, is curled up in a chair in his 22nd floor Manhattan offices, looking like a teenager with his shaggy hair, red polo, and bright blue sweater cardigan. Mid-sentence, he grabs a bottle of nose spray off the table, squirts it in one nostril, then the other, and jokes that all biotech CEOs should be willing to try their products. It was the way it worked in the 1950s. “The therapeutic dose is six sprays,” he says between squirts. “That’s six.”
Hey, check out all the research scientist jobs. Post your resume today!
